Nera K P, Brockmann E, Vihinen M, Smith C I, Mattsson P T
Department of Biochemistry and Food Chemistry, University of Turku, FIN-20014 Turku, Finland.
Protein Expr Purif. 2000 Dec;20(3):365-71. doi: 10.1006/prep.2000.1316.
Bruton's tyrosine kinase (Btk) is a cytoplasmic protein tyrosine kinase consisting of N-terminal pleckstrin homology (PH) domain followed by Tec homology (TH) domain, Src homology 3 and 2 (SH3 and SH2) domains, and a C-terminal kinase domain. Mutations in the human BTK gene cause the severe immunodeficiency disease X-linked agammaglobulinemia (XLA). The structural and functional basis of several XLA-causing mutations remains unknown, since only the structures of the PH and SH3 domains of human Btk are currently available. In this study, we overexpressed and purified a protein consisting of the SH3 and SH2 domains of human Btk for biochemical and structural analysis. The purified protein was only partially soluble and had a tendency to dimerize, which made it unsuitable for further studies. To overcome the problems of low solubility and dimerization, subdomain interactions were engineered without altering the function of the protein.
布鲁顿酪氨酸激酶(Btk)是一种细胞质蛋白酪氨酸激酶,由N端的普列克底物蛋白同源(PH)结构域、Tec同源(TH)结构域、Src同源3和2(SH3和SH2)结构域以及C端激酶结构域组成。人类BTK基因突变会导致严重免疫缺陷疾病X连锁无丙种球蛋白血症(XLA)。由于目前仅有人类Btk的PH和SH3结构域的结构信息,导致XLA的几种突变的结构和功能基础仍不清楚。在本研究中,我们过量表达并纯化了一种由人类Btk的SH3和SH2结构域组成的蛋白,用于生化和结构分析。纯化后的蛋白仅部分可溶且有二聚化倾向,这使其不适于进一步研究。为克服低溶解性和二聚化问题,我们在不改变蛋白功能的情况下对亚结构域相互作用进行了改造。